-
CTIC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
CTI BioPharma (CTIC)
Company Profile
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 24.21 mm | 24.21 mm | 24.21 mm | 24.21 mm | 24.21 mm | 24.21 mm |
Cash burn (monthly) | 2.07 mm | 6.06 mm | 3.08 mm | 4.49 mm | 10.37 mm | 6.86 mm |
Cash used (since last report) | 43.03 mm | 125.90 mm | 63.96 mm | 93.40 mm | 215.44 mm | 142.57 mm |
Cash remaining | -18.82 mm | -101.69 mm | -39.75 mm | -69.19 mm | -191.23 mm | -118.36 mm |
Runway (months of cash) | -9.1 | -16.8 | -12.9 | -15.4 | -18.4 | -17.3 |
13F holders | Current |
---|---|
Total holders | 8 |
Opened positions | 1 |
Closed positions | 127 |
Increased positions | 1 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 1.15 bn |
Total shares | 16.91 mm |
Total puts | 12.50 k |
Total calls | 51.02 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Growth Equity Opportunities V | 9.61 mm | $51.24 mm |
Stonepine Capital Management | 7.02 mm | $28.70 mm |
California State Teachers Retirement System | 126.41 k | $530.91 mm |
Ubs Global Asset Management Americas | 92.70 k | $389.34 mm |
Teacher Retirement System Of Texas | 31.27 k | $131.00 k |
Wolverine Trading | 15.76 k | $66.41 mm |
LGEN Legal & General | 9.34 k | $84.90 mm |
Biotechnology Value Fund L P | 0.00 | $0.00 |
FNY Investment Advisers | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Jun 23 | Parkinson David Ross | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.08 | 80,000 | 326.40 k | 0 |
26 Jun 23 | Parkinson David Ross | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.49 | 80,000 | 359.20 k | 0 |
26 Jun 23 | Parkinson David Ross | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.3 | 80,000 | 264.00 k | 0 |
26 Jun 23 | Parkinson David Ross | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1 | 126,000 | 126.00 k | 0 |
26 Jun 23 | Parkinson David Ross | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.8411 | 120,000 | 100.93 k | 0 |
26 Jun 23 | Parkinson David Ross | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.61 | 60,000 | 276.60 k | 0 |
26 Jun 23 | Parkinson David Ross | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.07 | 50,000 | 203.50 k | 0 |
26 Jun 23 | Adam R Craig | Common Stock | Dispose U | No | No | 9.1 | 31,470 | 286.38 k | 0 | |
26 Jun 23 | Adam R Craig | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.55 | 900,000 | 4.10 mm | 0 |
26 Jun 23 | Adam R Craig | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.49 | 1,115,000 | 5.01 mm | 0 |